GeneDx Holdings (WGS) Minority Interest (2020 - 2021)
GeneDx Holdings' (WGS) quarterly Minority Interest came in at $294.7 million in Q1 2021, down 16.55% quarter-over-quarter from $353.2 million in Q4 2020.
Analysis
GeneDx Holdings (WGS) Minority Interest (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Minority Interest for 2 consecutive years, with $294.7 million the latest figure, recorded in Q1 2021.
- On a quarterly basis, Minority Interest changed N/A year-over-year to $294.7 million in Q1 2021; TTM through Mar 2021 was $294.7 million, a N/A change from a year earlier, with the FY2020 full-year figure at $353.2 million, changed N/A from the prior year.
- Minority Interest was $294.7 million for Q1 2021 at GeneDx Holdings, down from $353.2 million in the prior quarter.
- Over five years, Minority Interest peaked at $353.2 million in Q4 2020 and troughed at $294.7 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn |